A randomized, blinded, multicenter trial of a gentamicin vancomycin gel (DFA-02) in patients undergoing abdominal surgery
Elliott Bennett‐Guerrero(Apple (Israel)), Kent Allenby(Dr. Reddy's Laboratories (United States)), Scott Berry(Queen's University), Felicia P. Rackowski(Dr. Reddy's Laboratories (United States)), Sergio D. Bergese(Stony Brook University Hospital), G. Ralph Corey(Duke Medical Center), Phillip Fleshner(Cedars-Sinai Medical Center), Karen W. Henderson(Clinical Research Institute), Alvaro M. Segura-Vasi(Clinical Research Associates), Kamal M.F. Itani(Boston University), Harold S. Minkowitz(Memorial Hermann Memorial City Medical Center), Laura H. Aberle(Clinical Research Institute), Martín E. Stryjewski(Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno)
Cited by 18
Related Papers
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by <i>Staphylococcus aureus</i>
|New England Journal of Medicine|2006|1.5k
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
|JAMA|2010|1.2k
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
|New England Journal of Medicine|2013|980